Oliver Luxxe Assets LLC Acquires 344 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Oliver Luxxe Assets LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 12,284 shares of the company’s stock after buying an additional 344 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in HCA Healthcare were worth $3,687,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $39,000. Capital Performance Advisors LLP bought a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $33,000. Canoe Financial LP acquired a new position in HCA Healthcare in the third quarter valued at $41,000. Finally, Northwest Investment Counselors LLC bought a new position in shares of HCA Healthcare in the 3rd quarter worth about $44,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on HCA. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $388.60.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock traded down $0.09 during trading hours on Monday, hitting $296.61. 854,034 shares of the company were exchanged, compared to its average volume of 1,008,546. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a fifty day simple moving average of $326.93 and a 200 day simple moving average of $354.99. The stock has a market capitalization of $75.13 billion, a price-to-earnings ratio of 13.32, a P/E/G ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.89%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.